期刊文献+

尼可地尔的临床应用现状及研究进展 被引量:5

Progress in Clinical Application and Research Progress of Nicorandil
下载PDF
导出
摘要 尼可地尔(Nicorandil)是第一个用于临床的具有硝酸酯类作用的离子通道开放剂,能够抑制Ca2+流入细胞以及促进K+的流出,从而促进血管平滑肌的舒张以及冠状动脉的扩张,因此在临床上将尼可地尔广泛用于治疗冠心病。尼可地尔能够改善稳定性及不稳定性心绞痛患者的生活质量,延长患者的生存时间。本文综合了国内外对尼可地尔的临床应用进行研究,对临床上使用尼可地尔治疗冠心病、保护心肌及改善预后具有指导意义。 Nicorandil is a potassium channel opener with nitrate effect,which was first used in clinical and it could inhibit the Ca2+ input and promote the K+ output to promote vascular smooth muscle relaxation and the expansion of coronary artery,so nicorandil was widely used in the treatment of coronary heart disease clinicaly. Nicorandil can significantly improve the quality of life and prolong survival time of patients with stable and unstable angina. This paper combines the research of nicorandil s clinical application to review and it has guiding significance to treat coronary heart disease,myocardial protection and improve the prognosis.
作者 魏香兰
出处 《中国卫生标准管理》 2016年第17期93-95,共3页 China Health Standard Management
关键词 尼可地尔 药理作用 冠心病 Nicorandil Pharmacological effects Coronary heart disease
  • 相关文献

参考文献16

  • 1Reimer KA, Murry CE, Jennings RB. Cardiac adaptation toischemia.Ischemic preconditioning increases myocardial tolerance tosubsequent ischemic episodes [ J ] . Circulation, 1990, 82 ( 6 ):2266-2268.
  • 2Cave A, G?irlick P. Re: Preconditioning with ischemia: a delay oflethal cell injury in ischemic myocardium [J ] . Journal of Molecular& Ccilubr Cardiology, 20(K?, 32 ( 9 ) : 1759-1760.
  • 3Zhu WL, Shan YD, Guo JX, et al. Ooublt*-blind, nmlticcnter,active-controlled, randomized clinical trial to assess the safety ;mdefficacy of orally administered nicomndil in patients with stable anginapectoris in China [ J ] . Ciriubtion Joiirniil, 2007, 71 ( 6 ) : H2fi-833.
  • 4陈峰,王爱玲,徐凤,周美玲.尼可地尔对大鼠心肌缺血再灌注损伤的保护作用研究[J].安徽医科大学学报,2011,46(9):923-925. 被引量:8
  • 5Kim JH, Jeong MH, Yun KH, et al. Myocardial protective effectsof nicorandil during percutaneous coronary intervention in patientswith unstable angina [ J ] . Circulation Journal, 2005,69 ( 3 ):306-310.
  • 6韩红彦,贾海珍,周琦,马丽.尼可地尔对不稳定型心绞痛患者PCI术后的心肌保护作用[J].疑难病杂志,2015,14(1):16-19. 被引量:32
  • 7Isono T,Kamihata H, Sucani Y, et al. Nicorandil suppressedmyocardial injury after percutaneous coron.iry intervention [j ].Iiitern-uional Journal of C'ardiology, 200S, 123 (2) : 123-128.
  • 8裴玮娜,谢瑞芹,崔炜,刘凡,姜云发,肖冰,闫智慧.曲美他嗪与尼可地尔对经皮冠状动脉介入治疗相关心肌损伤干预作用的比较[J].中国循环杂志,2014,29(4):256-260. 被引量:69
  • 9Oca S, Nishikavva H , Takeuchi M , et al. Impact of nicorandilto prevent reperfusion injury in patients with acute myocardialinfarction : Signiarr Multicenter Angioplasty Revascularization Trial(SMART) [J] . Circulation Journal, 2006, 70 ( 70 ) : I ()99-1104.
  • 10黄正新,王先宝,刘映峰.尼可地尔对急性心肌梗死患者冠状动脉介入术后心功能及临床预后的影响[J].实用医学杂志,2016,32(4):544-547. 被引量:30

二级参考文献99

  • 1简黎明,曾加礼.尼可地尔治疗冠心病心绞痛31例临床观察[J].现代医药卫生,2006,22(15):2273-2274. 被引量:5
  • 2《慢性稳定型心绞痛诊断与治疗指南》正式公布[J].中国全科医学,2007,10(7):601-601. 被引量:8
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 4马虹,陈小林.钾通道开放剂尼可地尔在冠心病稳定型心绞痛中的应用[J].中国医药导刊,2007,9(2):125-127. 被引量:17
  • 5Matsubara T,Minatoguchi S,Matsuo H,et al.Three minute,but notone minute,ischemia and nicorandil have a preconditioning effectin patients with coronary artery disease[J].J Am Coll Cardiol,2000,35(2):345-351.
  • 6Reimer KA,Murry CE,Jennings RB.Cardiac adaptation to ischemi-a.Ischemic preconditioning increases myocardial tolerance to subse-quent ischemic episodes[J].Circulation,1990,82(6):2266-2268.
  • 7Murry CE,Jennings RB,Reimer KA.Preconditioning with ischemi-a:a delay of lethal cell injury in ischemic myocardium[J].Circula-tion,1986,74(5):1124-1136.
  • 8Zhu WL,Shan YD,Guo JX,et al.Double-blind,multicenter,active-controlled,randomized clinical trial to assess the safety andefficacy of orally administered nicorandil in patients with stableangina pectoris in China[J].Circ J,2007,71(6):826-833.
  • 9Patel DJ,Purcell HJ,Fox KM.Cardioprotection by opening of the K(ATP)channel in unstable angina.Is this a clinical manifestation ofmyocardial preconditioning?Results of a randomized study withnicorandil.CESAR 2 investigation.Clinical European studies inangina and revascularization[J].Eur Heart J,1999,20(1):51-57.
  • 10Kishida H,Murao S.Effect of a new coronary vasodilator,nicoran-dil,on variant angina pectoris[J].Clin Pharmacol Ther,1987,42(2):166-174.

共引文献170

同被引文献65

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部